METASTATIC LUNG NEUROENDOCRINE NEOPLASM
Clinical trials for METASTATIC LUNG NEUROENDOCRINE NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new METASTATIC LUNG NEUROENDOCRINE NEOPLASM trials appear
Sign up with your email to follow new studies for METASTATIC LUNG NEUROENDOCRINE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for slowing advanced neuroendocrine tumors in Final-Stage trial
Disease control OngoingThis study is testing whether the drug cabozantinib can slow the growth of advanced neuroendocrine tumors better than a placebo in people whose cancer has continued to worsen despite prior treatments. About 298 participants with specific advanced neuroendocrine tumors will be ran…
Matched conditions: METASTATIC LUNG NEUROENDOCRINE NEOPLASM
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Early trial aims to boost radiation power against brain tumors
Disease control OngoingThis early-stage study is testing the safety and best dose of an experimental drug called berzosertib when given alongside standard whole brain radiation therapy. The goal is to see if the drug combination works better than standard care to control cancer that has spread from the…
Matched conditions: METASTATIC LUNG NEUROENDOCRINE NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC